Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter September 2017

News: Gene therapy for cancer halted after patient death
Two trials assessing gene therapy for blood cancer have been put on hold by the US Food and Drug Administration (FDA), following a patient fatality. The therapy, known as 'off-the-shelf' CAR-T immunotherapy, used genetically modified immune system T cells to target cancer, yet unlike other trials the cells were taken from a healthy donor instead of the patient. It was hoped this therapy would prove easier and less expensive to produce.

News: FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL
The U.S. Food and Drug Administration (FDA) has issued a press release making the first even gene therapy available for treatment of children with a form of acute lymphoblastic leukemia (ALL). The drug Kymriah (tisagenlecleucel) is the first of its kind that uses gene therapy to treat patients with this condition. The release was updated yesterday identifying the designantions that were granted to Kymriah.

Conference: Gene Therapy for Rare Disorders 2017
Gene Therapy for Rare Disorders 2017 will focus exclusively on how drug developers can progress gene therapies to market more effectively. Built using insights from Pfizer, GSK, UniQure and Genzyme, this unique conference will delve into the key clinical, regulatory, manufacturing, pricing and reimbursement hurdles that need to be overcome to realize the commercial potential of gene therapies. Join your peers to evaluate the latest case studies and lessons learned from the rapid progress of ocular, CNS and liver gene therapies, to accelerate your development of marketable gene therapies.
Gene Therapy Net members receive 20% discount with code: GTN

Date: October 31 - November 2, 2017
Venue: London, UK.

View Full Agenda & Abstracts at:

Conference: Combined CAR-T Congress Europe Congress
Combined CAR-T Congress Europe gathers thought leaders from biotech, big pharma, academia and the wider service community to address the challenges and opportunities of CAR-T therapies – including CAR-T, CAR-Tregs and combined therapies - that are critical to furthering the development of viable T-cell therapies. Exploring ground-breaking developments in this fast growing field, the event will provide the opportunity to collaborate to create a commercially viable, effective and safe therapy. Gene Therapy Net members receive 10% discount with code: GTN10

Date: January 30-31, 2018
Venue: Berlin, Gemany.

View Full Agenda & Abstracts at:

- 19 - 21 September 2017, 3rd Annual Phacilitate Cell & Gene Therapy Europe, Berlin, Germany
- 25 - 28 September 2017, Cell & Gene Therapy Bioprocessing & Commercialization, Boston, MA
- 27 - 28 September 2017, Annual Summit on Cell Therapy and Molecular Medicine, Chicago, Il
- 4 – 6 October 2017, Cell & Gene Meeting on the Mesa, La Jolla, CA
- 17 – 20 October 2017, XXV Congress of the European Society of Gene and Cell Therapy (ESGCT), Berlin, Germany
- 18 – 19 October 2017, Market Access for Cell and Gene Therapies Congress, London, UK
- 31 October – 2 November 2017, Gene Therapy for Rare Disorders Europe, London, UK
- 9 - 10 November 2017, 3rd Annual Genome Editing Congress, London, UK
- 9 - 10 November 2017, 3rd Annual Cell & Gene Therapy Congress, London, UK
- 13 - 15 November 2017, World Orphan Drug Congress, Barcelona, Spain
- 15 - 17 November 2017, 16th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, California
- 23 - 25 January 2018, Cell & Gene Therapy World event 2018, Miami, Fl
- 15 March 2018, British Society for Gene and Cell Therapy (BSGCT) Public Engagement 2018, Oxford, UK
- 15 - 17 March 2018, 7th International Conference and Exhibition on Cell and Gene Therapy, London, UK
- 27 April 2018, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), Cardiff, Wales, UK
- 16 - 19 May 2018, American Society of Gene and Cell Therapy (ASGCT) 21th Annual Meeting, Chicago, IL


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?